ResMed Inc. (RMD) — Analysis Summary
ResMed Inc. (RMD) has a market cap of $27.64B with year-over-year revenue growth of +9.8%. Net margin stands at 27.2%. The stock trades at a P/E ratio of 18.2.
Key Takeaways
- Revenue changed +9.8% year-over-year
- Net margin of 27.2%
- P/E ratio of 18.2
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, RMD posted revenue growth of +9.8% and trades at a P/E of 18.2.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.